Jubilant Life Sciences drops after revising prices of products
DSIJ Intelligence / 20 Dec 2016
Jubilant Life Sciences has increased its Beta Picoline, 3-Cyanopyridine and Vitamin B3 (Niacin & Niacinamide) prices by upto 15 per cent with immediate effect, for non-contract customers and wherever existing contracts permit.
Jubilant Life Sciences has increased its Beta Picoline, 3-Cyanopyridine and Vitamin B3 (Niacin & Niacinamide) prices by upto 15 per cent with immediate effect, for non-contract customers and wherever existing contracts permit.
On the financial front, Jubilant Lifesciences’ revenue has decreased by 4.58 per cent to Rs 1386 crore in Q2FY17 as compared to same period in previous financial year. However, the company’s operating profit has risen by 5.32 per cent to Rs 340 crore in Q2FY17 on a yearly basis. Its net profit has increased by 14.52 per cent to Rs 145 crore in Q2FY17 as compared to same period in previous fiscal.
The share price of Jubilant Life Sciences has declined by 4.13 per cent on bourses in early trades; and is trading at Rs 600 on an intraday basis.The company is witnessing a volume of 79339. Its share price is trading below 300 SMA levels of Rs 648.75. Jubilant Life Sciences has given about negative 1.32 returns during the last month.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.